Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients

American Journal of Transplantation

Volumn 11, Issue 12, 2011, Pages 2751-2754

  Schaffer, S A ^a,b   Husain, S ^a,b   Delgado, D H ^a,b   Kavanaugh, L ^b   Ross, H J ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Adjuvant; cellular rejection; heart transplant; influenza; vaccination

Indexed keywords

CALCINEURIN INHIBITOR; INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 VIRUS ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ACUTE GRAFT REJECTION; ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CANADA; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VACCINATION; VIRUS REPLICATION;

EID: 82455175225     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03743.x     Document Type: Article

References (16)

1. Vilchez RA, McCurry K, Dauber J, et al,. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-291. (Pubitemid 36330248)
2. Wendt CH,. Community respiratory viruses: Organ transplant recipients. Am J Med 1997; 102: 31-36; Discussion 42- 43.
3. Fiore AE, Shay DK, Broder K, et al,. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58 (RR-8): 1-52.
4. WHO. New influenza A (H1N1) virus: Global epidemiological situation, June 2009. Wkly Epidemiol Rec 2009; 84: 249-257.
5. WHO. Strategic advisory group of experts on immunization - Report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec 2009; 84: 301-304.
6. WHO. Summary of: WHO virtual consultation on the safety of adjuvanted influenza vaccines. 2009 [updated June 3, 2009; cited 2011 May 1, 2011]; Available from: http://www.who.int/vaccine-research/documents/Report-on- consultation-on-adjuvant-safety-2.pdf.
7. HealthCanada. Notice of decision for AREPANRIX™ H1N1. Ottawa, ON, Canada 2009 [updated November 30, 2009]; 30: 685-690. Available from: http://www.hc-sc.gc.ca/dhpmps/alt-formats/pdf/prodpharma/sbd-smd/ phase1-decision/drugmed/nd-ad-2009-arepanrix-h1n1-132070-eng.pdf.
8. Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A,. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: Coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant 2011; 30: 685-690.
9. Billingham ME, Cary NR, Hammond ME, et al., Heart Rejection Study Group. The International Society for Heart Transplantation. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant 1990; 9: 587-593.
10. Stewart S, Winters GL, Fishbein MC, et al,. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-1720. (Pubitemid 41641841)
11. Campbell DS, Rumley MH,. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39: 408-414. (Pubitemid 27250368)
12. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A,. Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 1999; 18: 220-225. (Pubitemid 29177899)
13. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC,. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17: 1075-1080. (Pubitemid 28547275)
14. Magnani G, Falchetti E, Pollini G, et al,. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: A prospective randomised controlled study. J Heart Lung Transplant 2005; 24: 588-592. (Pubitemid 40693882)
15. Brunner-La Rocca HP, Sutsch G, Schneider J, Follath F, Kiowski W,. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation 1996; 94: 1334-1338. (Pubitemid 26307262)
16. Danziger-Isakov L, Cherkassky L, Siegel H, et al,. Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation 2010; 89: 838-844.